Nvax stock price hovered at $4

NVAX stock price hovered at $4.65 today, reflecting cautious buying from retail investors while institutional inflows remain muted. Sector-wide biotech ETF declines have weighed on NVAX, though technical charts show potential support near $4.50 if broader market sentiment stabilizes. NVAX | Novavax Inc. Stock Overview (U.S.: Nasdaq) | Barron's The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. NVAX stock price slipped 1.8% to $4.56 as traders reacted to weaker-than-expected health sector index performance. Analysts warn that unless NVAX shows revenue growth in next quarter, downside risk to $4.20 remains on the table.